Increasing Number Of Vaccination Programs Fueling The Growth Of The Market Due To Rising Public Awareness And Improved Accessibility Is Supporting Development Across The Shingles Vaccine Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Shingles Vaccine Market During The 2026–2030 Period?

The market for shingles vaccines has experienced significant expansion recently. Projections indicate its value will escalate from $5.55 billion in 2025 to $6.37 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.8%. Historically, this expansion was driven by factors such as the restricted supply of shingles vaccines, a dependence on live attenuated versions, the expanding demographic of older individuals, a rise in herpes zoster cases, and enhanced understanding of the advantages of immunization.

The shingles vaccine market is set for significant expansion over the next few years. It is forecast to grow to $10.96 billion in 2030, driven by a compound annual growth rate (CAGR) of 14.5%. This projected growth can be attributed to several factors, including the continuous development of recombinant and subunit vaccines, the wider reach of public and private vaccination campaigns, the increasing utilization of online and retail pharmacy distribution channels, a rise in government and healthcare initiatives focused on immunizing the elderly, and the integration of digital health monitoring to improve vaccination adherence. Prominent trends expected in this forecast period encompass the growing adoption of recombinant and subunit shingles vaccines, enhanced awareness of shingles prevention among older adults, the expansion of vaccination programs via hospital and retail pharmacies, an increase in online pharmacies and e-commerce for vaccine distribution, and a strategic emphasis on age-specific immunization approaches for individuals aged 50 and above.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27413&type=smp

What Core Drivers Are Transforming The Shingles Vaccine Market?

The shingles vaccine market is anticipated to expand due to the rising number of vaccination programs. These initiatives are structured public health efforts aimed at systematically vaccinating communities to prevent the transmission of infectious illnesses. An uptick in such programs stems from heightened awareness regarding preventive healthcare, prompting more individuals to seek vaccination against diseases. They boost the uptake of the shingles vaccine through greater public understanding and availability, making them particularly suitable for older adults and high-risk demographics. By advocating for prompt and widespread immunization, these programs mitigate the risk of shingles and associated complications, thereby enhancing general community health. For example, data from July 2025, provided by the World Health Organization, a Switzerland-based Intergovernmental organization, shows that the coverage for the first dose of human papillomavirus (HPV) vaccine among girls grew from 27% in 2023 to 31% in 2024. Consequently, the expanding volume of vaccination programs is a key factor driving the growth of the shingles vaccine market.

What Segment Categories Are Evaluated In The Shingles Vaccine Market Study?

The shingles vaccine market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine

2) By Product: Shingrix, Zostavax, Skyzoster

3) By Age Group: 50-59 Years, 60-69 Years, 70 Years And Above

4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

5) By End User: Hospitals, Clinics, Pharmacies

Subsegments:

1) By Live Attenuated Vaccine: Virus Strain A, Virus Strain B, Virus Strain C

2) By Recombinant Vaccine: Recombinant Protein Vaccine, Recombinant Vector Vaccine, Recombinant Deoxyribonucleic Acid Vaccine

3) By Subunit Vaccine: Protein Subunit Vaccine, Conjugate Subunit Vaccine

What Trends Are Impacting The Shingles Vaccine Market?

Leading companies in the shingles vaccine market are concentrating on developing innovative vaccine formulations, such as recombinant adjuvanted vaccines, to improve immune response and offer long-lasting protection against shingles. These recombinant adjuvanted vaccines utilize laboratory-produced viral proteins combined with substances known as adjuvants to boost the body’s immune response for enhanced and more prolonged protection. For instance, in April 2023, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharmaceutical company, introduced Shingrix, a shingles vaccine. Shingrix is an inactivated, recombinant adjuvanted subunit vaccine administered intramuscularly in two doses for adults aged 50 and above, designed to prevent shingles (herpes zoster) and its associated complication, post-herpetic neuralgia. This highly effective vaccine provides over 90% protection against shingles, with robust and sustained immunity lasting at least 10 years, even in older adults and immunocompromised individuals.

Which Organizations Are Operating Within The Shingles Vaccine Market?

Major companies operating in the shingles vaccine market are Merck & Co. Inc., GSK plc, SK bioscience, Pfizer Inc, GeneOne Life Science, Curevo Inc, Novavax Inc

Access The Complete Shingles Vaccine Market Report:

https://www.thebusinessresearchcompany.com/report/shingles-vaccine-global-market-report

Which Region Contributes The Most To The Shingles Vaccine Market?

North America was the largest region in the shingles vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shingles vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Shingles Vaccine Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27413&type=smp

Browse Through More Reports Similar to the Global Shingles Vaccine Market 2026, By The Business Research Company

Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/construction-global-market-report

Folding Furniture Market Report 2026

https://www.thebusinessresearchcompany.com/report/folding-furniture-global-market-report

Foldable Houses Market Report 2026

https://www.thebusinessresearchcompany.com/report/foldable-houses-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795